| Literature DB >> 33989755 |
Lisa Belfiore1, Behnaz Aghaei2, Andrew M K Law2, Jeremy C Dobrowolski2, Lyndon J Raftery2, Angie D Tjandra2, Christine Yee2, Alberto Piloni2, Alexander Volkerling2, Cameron J Ferris2, Martin Engel2.
Abstract
Successful preclinical drug testing relies in part on data generated using in vitro cell culture models that recapitulate the structure and function of tumours and other tissues in vivo. The growing evidence that 3D cell models can more accurately predict the efficacy of drug responses compared to traditionally utilised 2D cell culture systems has led to continuous scientific and technological advances that enable better physiologically representative in vitro modelling of in vivo tissues. This review will provide an overview of the utility of current 3D cell models from a drug screening perspective and explore the future of 3D cell models for drug discovery applications.Entities:
Keywords: 3D cell culture; bioprinting; drug screening
Year: 2021 PMID: 33989755 DOI: 10.1016/j.ejps.2021.105876
Source DB: PubMed Journal: Eur J Pharm Sci ISSN: 0928-0987 Impact factor: 4.384